Researchers at Sher-I-Kashmir Institute of Medical Sciences Soura, Srinagar (SKIMSA) have designed an advanced treatment that can provide major relief to patients suffering from pancreatic tumors.
Director of SKIMSA, Dr. Showkat Ali Zargar on disclosed here today that with the new advanced treatment the time of the operation has reduced. When the time limit is reduced reduces in a particular surgery, automatically the complications are less, as the blood loss is very less and the patients will be hospitalized for shorter period.
Pancreatic Cancer
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
Advertisement
Dr Zargar has been performing this surgery since 4-5 years and has got a vast experience and knowledge about it. With this advanced surgery, the death rate has been reduced and it has benefited the people to a great extent.
With the aim to minimize rate of mortality senior doctors have come up with Superior Approach Technique (SAT) for the treatment of periampullary and pancreatic head tumors which claims hundreds of lives in the valley each year.
The exclusive surgery is being considered one of the rarest techniques developed out of indigenous expertise and efficiency to treat patients with pancreatic tumor.
Head of the department surgical gastroenterology, Dr. Omar Javed Shah said that the technique would help change lives of hundreds of patients who cannot travel abroad for treatment.
"We have been able to help poor community, majority of the people, who cannot go outside (abroad) . We have designed new treatments, new techniques, which have been accepted worldwide, ' said Shah.
Introduced by SKIMS specialists, SAT is simple in use and has significantly reduced blood loss, operative time and mortality rate.
Traditionally pancreatic tumors are treated with conventional surgical technique, called 'Classical Whipple's method' which is difficult and associated with high morbidity and mortality besides being a time consuming procedure.
Reported incidences of pancreatic cancer has risen gradually over the years and Pancreatic cancer is the fourth leading cause of death among both men and women, comprising six percent of all cancer-related deaths.
Source: ANI
Advertisement
The exclusive surgery is being considered one of the rarest techniques developed out of indigenous expertise and efficiency to treat patients with pancreatic tumor.
Head of the department surgical gastroenterology, Dr. Omar Javed Shah said that the technique would help change lives of hundreds of patients who cannot travel abroad for treatment.
"We have been able to help poor community, majority of the people, who cannot go outside (abroad) . We have designed new treatments, new techniques, which have been accepted worldwide, ' said Shah.
Introduced by SKIMS specialists, SAT is simple in use and has significantly reduced blood loss, operative time and mortality rate.
Traditionally pancreatic tumors are treated with conventional surgical technique, called 'Classical Whipple's method' which is difficult and associated with high morbidity and mortality besides being a time consuming procedure.
Reported incidences of pancreatic cancer has risen gradually over the years and Pancreatic cancer is the fourth leading cause of death among both men and women, comprising six percent of all cancer-related deaths.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Colon cancer's hidden link revealed in microbiome study.
Breast cancer patients in the obese or overweight category can greatly benefit from a telephone-based weight management program in achieving significant weight loss.
A new study assessed the association of cigarette smoking and vaping on cancer-related symptom burden (fatigue, pain, emotional problems) and quality of life.
Scientists are making strides in personalized breast cancer therapy by developing a highly accurate molecular classifier test for breast cancer patients.